Search Results - Janice Castillo
- Showing 1 - 3 results of 3
-
1
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers by Genmin Lu, Pamela B. Conley, Janet M. Leeds, Mark J. Karbarz, Gallia G. Levy, Vandana Mathur, Janice Castillo, Mark Crowther, John T. Curnutte
Published 2020Artigo -
2
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity by Deborah Siegal, John T. Curnutte, Stuart J. Connolly, Genmin Lu, Pamela B. Conley, Brian L. Wiens, Vandana Mathur, Janice Castillo, Michele Bronson, Janet M. Leeds, F. Mar, Alex Gold, Mark Crowther
Published 2015Artigo -
3
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa by Deborah Siegal, Genmin Lu, Janet M. Leeds, Mark J. Karbarz, Janice Castillo, Vandana Mathur, Athiwat Hutchaleelaha, Uma Sinha, Michael M. Kitt, Matt McClure, Stanley J. Hollenbach, John T. Curnutte, Pamela B. Conley, Mark Crowther
Published 2017Artigo